PHOX2B mutations and genetic predisposition to neuroblastoma

Oncogene

Volumn 24, Issue 18, 2005, Pages 3050-3053

  Perri, Patrizia ^a   Bachetti, Tiziana ^b   Longo, Luca ^c   Matera, Ivana ^b   Seri, Marco ^d   Tonini, Gian Paolo ^c   Ceccherini, Isabella ^b  

^a CENTRO DI BIOTECNOLOGIE AVANZATE   (Italy)

^b G GASLINI INSTITUTE   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Cancer predisposition; Familial neuroblastoma; Oligogenic model; PHOX2B

Indexed keywords

ARTICLE; CANCER SUSCEPTIBILITY; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE TRANSMISSION; EXON; FAMILIAL CANCER; FEMALE; GENE IDENTIFICATION; GENE LOCUS; GENE MAPPING; GENE MUTATION; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION; GENETIC SCREENING; GENOME ANALYSIS; GERM LINE; HIRSCHSPRUNG DISEASE; HOMEOBOX; HUMAN; INFANT; ITALY; LINKAGE ANALYSIS; MALE; MICROSATELLITE MARKER; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NEURAL CREST CELL; NEUROBLASTOMA; NEWBORN; PAIRED LIKE HOMEOBOX 2B GENE; PENETRANCE; PHENOTYPE; PRIORITY JOURNAL; GENETICS; METABOLISM; MUTATION; PEDIGREE;

HOMEODOMAIN PROTEIN; NBPHOX PROTEIN; TRANSCRIPTION FACTOR;

FEMALE; GENETIC PREDISPOSITION TO DISEASE; HOMEODOMAIN PROTEINS; HUMANS; MALE; MUTATION; NEUROBLASTOMA; PEDIGREE; TRANSCRIPTION FACTORS;

EID: 18344381314     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208532     Document Type: Article

References (19)

1. Amiel J, Laudier B, Attie-Bitach T, Trang H, de Pontual L, Gener B, Trochet D, Etchevers H, Ray P, Simonneau M, Vekemans M, Munnich A, Gaultier C and Lyonnet S. (2003). Nat. Genet., 33, 459-461.
2. Brodeur GM, Pritchard J, Berthold F, Carlsen NL, Castel V, Castelberry RP, De Bernardi B, Evans AE, Favrot M and Hedborg F. (1993). J. Clin. Oncol, 11, 1466-1477.
3. Croaker GD, Shi E, Simpson E, Cartmill T and Cass DT. (1998). Arch. Dis. Child, 78, 316-322.
4. Griseri P, Mishto M, Priolo M, Pesce B, Hamel BCJ, Romeo G, Ravazzolo R and Ceccherini I. (2000). Gene Funct. Dis., 1, 184-188.
5. Katsanis N. (2004). Hum. Mol. Genet., 13 (Spec. No. 1), R65-R71.
6. Knudson AG and Strong LC. (1972). Am. J. Hum. Genet., 24, 514-532.
7. Limpt VV, Schramm A, Lakeman A, Sluis PV, Chan A, Noesel MV, Baas F, Caron H, Eggert A and Versteeg R. (2004). Oncogene, 23, 9280-9288.
8. Maris JM, Weiss MJ, Mosse Y, Hii G, Guo C, White PS, Hogarty MD, Mirensky T, Brodeur GM, Rebbeck TR, Urbanek M and Shusterman S. (2002). Cancer Res., 62, 6651-6658.
9. Matera I, Bachetti T, Puppo F, Di Duca M, Morandi F, Casiraghi GM, Cilio MR, Hennekam R, Hofstra R, Schober JG, Ravazzolo R, Ottonello G and Ceccherini I. (2004). J. Med. Genet., 41, 373-380.
10. Ming JE and Muenke M. (2002). Am. J. Hum. Genet., 71, 1017-1032.
11. Mosse YP, Laudenslager M, Khazi D, Carlisle AJ, Winter CL, Rappaport E and Maris JM. (2004). Am. J. Hum. Genet., 75, 730-731.
12. Origone P, Defferrari R, Mazzocco K, Lo Cunsolo C, De Bernardi B and Tonini GP. (2003). Am. J. Med. Genet., 118A, 309-313.
13. Pattyn A, Morin X, Cremer H, Goridis C and Brunet JF. (1999). Nature, 399, 366-370.
14. Perri P, Longo L, Cusano R, McConville CM, Rees SA, Devoto M, Conte M, Ferrara GB, Seri M, Romeo G and Tonini GP. (2002a). Oncogene, 21, 8356-8360.
15. Perri P, Longo L, McConville C, Cusano R, Rees SA, Seri M, Conte M, Romeo G, Devoto M and Tonini GP. (2002b). Ann. NY Acad. Sci., 963, 74-84.
16. Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV and Roald B. (1999). Cancer, 86, 349-363.
17. Tonini GP, Longo L, Coco S and Perri P. (2003). Cancer Lett., 197, 41-45.
18. Trochet D, Bourdeaut F, Janoueix-Lerosey I, Deville A, De Pontual L, Schleiermacher G, Coze C, Philip N, Frebourg T, Munnich A, Lyonnet S, Delattre O and Amiel J. (2004). Am. J. Hum. Genet., 74, 761-764.
19. Weese-Mayer DE, Berry-Kravis EM, Zhou L, Maher BS, Silvestri JM, Curran ME and Marazita ML. (2003). Am. J. Med. Genet., 123A, 267-278.